Jade Biosciences Inc (JBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 20,336 | 17,639 | 15,851 | 14,152 | 12,215 |
| Operating Income | -20,336 | -17,639 | -15,851 | -14,152 | -12,215 |
| Other Income | 1,311 | 1,119 | 854 | 564 | 224 |
| Pre-tax Income | -19,025 | -16,520 | -14,997 | -13,588 | -11,991 |
| Net Income Continuous | -19,025 | -16,520 | -15,022 | -13,588 | -11,991 |
| Net Income | $-19,025 | $-16,520 | $-15,022 | $-13,588 | $-11,991 |
| EPS Basic Total Ops | -26.67 | -23.51 | -21.05 | -19.65 | -17.19 |
| EPS Basic Continuous Ops | -26.52 | -23.39 | -21.44 | -19.50 | -17.24 |
| EPS Diluted Total Ops | -26.67 | -23.51 | -21.05 | -19.65 | -17.19 |
| EPS Diluted Continuous Ops | -26.52 | -23.39 | -21.44 | -19.50 | -17.24 |
| EBITDA(a) | $-20,953 | $-18,289 | $-16,417 | $-14,424 | $-12,259 |